Nan Bi

17PUBLICATIONS

40CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapyCell physiologyCancer diagnosis

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (17)

Sort by Publication Date:

|May 14, 2026

The Addition of Concurrent Immune Checkpoint Inhibitors for Chemoradiotherapy With Consolidative Immune Checkpoint Inhibitors in Unresectable Cancers: A Systematic Review and Meta-Analysis.

|Apr 10, 2026

Comparing the Prognosis of Non-Small Cell Lung Cancer Patients Who Did Not Undergo Surgery After Neoadjuvant Chemotherapy Combined With Immunotherapy: A Retrospective Study.

Zhenghui Ma, Yuqi Wu, Guangqian Ji

|Feb 06, 2026

Interpretable deep learning model of circulating genomics for quantitative survival prediction in advanced non-small cell lung cancer.

Yu Wang, Yi-Tong Li, Ming-Hao Wang

|Jan 06, 2026

PRIME: an interpretable artificial intelligence model based on liquid biopsy improves prediction of progression risk in non-small cell lung cancer.

Yu Wang, Yong-Bo Xiang, Xiao-Wei Chen

|Oct 15, 2025

Simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal squamous cell carcinoma: A multicenter, open-label, randomized, phase III clinical trial.

Weiming Han, Linrui Gao, Xiaomin Wang

|May 21, 2025

Single-arm phase II study of consolidation serplulimab following hypofractionated radiotherapy with concurrent chemotherapy for patients with limited stage small-cell lung cancer: ASTRUM-LC01 study protocol.

Yuqi Wu, Lei Deng, Jianyang Wang

Pageof 3

Frequent Collaborators

Luhua Wang

Lei Deng

Yuqi Wu

Yibo Gao

Xin Wang

Xu Tong

Zhouguang Hui

Xu Huang

Jingbo Wang

Hua Ren

Frequent Collaborators

Luhua Wang

Lei Deng

Yuqi Wu

Yibo Gao